Tami Martin, R.N.
2019
In 2019, Tami Martin, R.N. earned a total compensation of $874.8K as Senior Vice President, Regulatory Affairs at Supernus Pharmaceuticals, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $91,400 |
|---|---|
| Option Awards | $424,540 |
| Salary | $316,891 |
| Other | $41,988 |
| Total | $874,819 |
RN received $424.5K in option awards, accounting for 49% of the total pay in 2019.
RN also received $91.4K in non-equity incentive plan, $316.9K in salary and $42K in other compensation.
Rankings
In 2019, Tami Martin, R.N.'s compensation ranked 9,860th out of 13,971 executives tracked by ExecPay. In other words, RN earned more than 29.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,860 out of 13,971 | 29th |
Division Manufacturing | 3,980 out of 5,695 | 30th |
Major group Chemicals And Allied Products | 1,514 out of 2,194 | 31st |
Industry group Drugs | 1,294 out of 1,880 | 31st |
Industry Pharmaceutical Preparations | 961 out of 1,392 | 31st |
Pay ratio
| Tami Martin, R.N.'s Pay | $874,819 |
|---|---|
| Median Employee's Pay | $135,666 |
| Pay Ratio | 6to 1 |
In 2019, the annual total compensation of Tami Martin, R.N. was $874,819.
The annual total compensation of the median employee at Supernus Pharmaceuticals was $135,666.
The ratio of Tami Martin, R.N.'s pay to the pay of median employee was therefore 6 to one.
Source: SEC filing on April 24, 2020.
RN's colleagues
We found four more compensation records of executives who worked with Tami Martin, R.N. at Supernus Pharmaceuticals in 2019.